









Markets
/
Stocks
/
nasdaq-ecor
/

electroCore, Inc.

ECOR

4.740USD

-0.210-4.24%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

35.39MMarket Cap

LossP/E TTM



electroCore, Inc.

4.740

-0.210-4.24%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of electroCore, Inc.

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

electroCore, Inc.'s Score

Industry at a Glance

Industry Ranking

105 / 210

Overall Ranking

235 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 5 analysts

Buy

Current Rating

21.080

Target Price

+325.86%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

electroCore, Inc. Highlights

StrengthsRisks

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 193.09% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 25.18M.

Fairly Valued

The company’s latest PE is -2.98, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.17M shares, decreasing 18.35% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 180.69K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.69.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 7.25, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 7.38M, representing a year-over-year increase of 20.23%, while its net profit experienced a year-over-year increase of 38.27%.

Score

Industry at a Glance

Previous score

7.25

Change



Financials

5.39

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.69

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.87

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.07

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.22

Key Metrics

Free cash flow

No Data

electroCore, Inc.'s Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 7.27, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -2.98, which is -77.55% below the recent high of -0.67 and -309.84% above the recent low of -12.19.

Score

Industry at a Glance

Previous score

7.27

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 105/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

The company’s current earnings forecast score is 8.40, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for electroCore, Inc. is 23.40, with a high of 25.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.40

Change

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts

Buy

Current Rating

21.080

Target Price

+325.86%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

electroCore, Inc.

ECOR

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 6.87, which is higher than the Healthcare Equipment & Supplies industry's average of 6.82. Sideways: Currently, the stock price is trading between the resistance level at 5.26 and the support level at 4.35, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.87

Change

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.007

Sell

RSI(14)

41.911

Neutral

STOCH(KDJ)(9,3,3)

43.473

Neutral

ATR(14)

0.251

Low Volatility

CCI(14)

-222.430

Oversold

Williams %R

64.935

Sell

TRIX(12,20)

-0.080

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

4.938

Sell

MA10

4.937

Sell

MA20

4.983

Sell

MA50

5.015

Sell

MA100

5.555

Sell

MA200

7.592

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-05

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 14.68%, representing a quarter-over-quarter decrease of 68.95%. The largest institutional shareholder is The Vanguard, holding a total of 232.33K shares, representing 2.91% of shares outstanding, with 12.75% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Zhang (Tianyi)

734.64K

Theofilos (Charles Steve)

444.53K

Hilve Holdings Ltd

432.00K

Errico (Thomas J.)

306.38K

+9.51%

AWM Investment Company, Inc.

269.93K

-15.15%

The Vanguard Group, Inc.

Star Investors

232.33K

Goldberger (Daniel S)

184.90K

+0.54%

Renaissance Technologies LLC

Star Investors

180.69K

+1.27%

Happy Holstein Management, LLC

153.17K

MAZ Partners, L.P.

115.52K

-57.52%

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 2.08, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.34. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.